MONDAY, Feb. 16 (HealthDay News) -- When Dr. Earl S. Ford read that the American Academy of Pediatrics (AAP) was recommending that children as young as 8 be given cholesterol-lowering statins, he decided to check on the numbers.

His conclusion, published in the Feb. 16 online issue of Circulation: Less than 1 percent of American children aged 12 to 17 meet the criteria for taking those drugs.

Ford is a medical officer in the U.S. Public Health Service, but his reaction to the recommendation was the same puzzlement experienced by many parents.

"I remember that after the guidelines came out, there was a lot of media stories about them," Ford said. "It was a big media debate. I just wasn't sure that there were any good data out there, so I thought I would provide insights to that."

What he did was hardly esoteric, Ford said. "A lot of people could have done it," he said. "The data are out in the public domain, and anyone who has a computer can work with them. I'm sure a lot of people had a similar thought like the one I had."

The data came from the National Health and Nutrition Examination Survey 1999 to 2006, which included information on almost 10,000 youngsters aged 6 to 17, including readings of "bad" LDL cholesterol on 2,700 adolescents aged 12 to 17.

The AAP guidelines suggest that statins be considered for children with no risk factors other than cholesterol readings 190 or higher. Statins are also suggested for a 130 or higher reading for a youngster with diabetes or a 160 reading with other risk factors, such as obesity or smoking.

Running the numbers through the computer, Ford and his colleagues concluded that statin therapy would be warranted for 0.8 percent of adolescents aged 12 to 17 -- a total of 200,000 in the United States.

Whether that is a large number "depends on what you think of less than 1 percent," Ford said.